Project Grant K01CA292141
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$177K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
This $753,446 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) aims to develop and evaluate an intervention to improve cervical cancer screening and follow-up in three diverse, underserved populations: urban inner city Blacks/Haitians in Boston, Hispanic immigrants in Florida, and Hawaiian Natives/Pacific Islanders in Hawaii. The intervention, called DOSE-CC, combines education and quality improvement methods using a performance...
This Project Grant award, in the amount of $269,942, was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. The award aims to develop and pilot test a community health worker (CHW) intervention to improve lung cancer screening (LCS) uptake and address disparities in LCS among Black and Hispanic communities served by community health centers. The key products and services to be delivered include: 1) Jointly...
This federal Project Grant award, totaling $477,869.00, was provided by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395). The grant aims to develop tailored, multilevel cervical cancer interventions for ethnically diverse Black women, including African American women and Black African immigrant women. The key objectives are to: 1) identify multilevel determinants of routine cervical cancer screening and follow-up adherence among these populations,...
This $432,304 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will fund research to develop enhanced cancer risk prediction models for underrepresented Black and Hispanic populations. The key products to be delivered include: Novel data integration methods that can effectively leverage diverse data sources, including electronic health records and biobanks, while addressing challenges around data privacy and the...
This Project Grant award of $154,666.00 from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will fund a study titled "Caregivers-Patients Support to Latinx Coping with Advanced-Cancer" at the Ponce Medical School Foundation Inc. in Puerto Rico. The goal is to refine and pilot a five-session, 60-minute telehealth intervention called CASA (Caregivers Patients Support to Latinx Coping with Advanced Cancer) for Hispanic/Latinx patients with advanced cancer...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $197,640 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop implementation strategies to initiate colorectal cancer (CRC) screening in previously unscreened individuals aged 45 to 54 at a predominantly Black community health center in Boston, Massachusetts. The key objectives are to: (1) identify system-level determinants of...
This federal Project Grant award for $4,036,820.00, granted by the National Institute on Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research (CFDA 93.307) program, will fund a 5-year multilevel peer-to-peer education program to increase Human Papilloma Virus (HPV) vaccinations and utilization of school-based health centers (SBHCs) among medically underserved adolescents. The primary awardee, Kaiser Foundation Hospitals, will develop tailored...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) in the amount of $192,780 provides funding to the University of Alabama at Birmingham (UAB) to optimize a bundled breast and cervical cancer screening program in Cameroon, Africa. The goal is to establish the reach and effectiveness of the screening program, identify implementation outcomes and barriers, and develop patient-centered strategies to disseminate the evidence-based...
This federal Project Grant award, provided by the National Cancer Institute (CFDA 93.396 Cancer Biology Research program), aims to develop highly effective cancer immunotherapeutic vaccines to address global health disparities in cervical cancer associated with human papillomavirus (HPV) 16 variants. The $630,506 award, spanning 2025-2029, will fund research to: 1) characterize immune evasion by studying presentation of HPV E6/E7 epitope variants across different human MHC-1 alleles; 2) evaluate...
This $171,989 Project Grant awarded by the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) will support the University of Florida in adapting and evaluating the PINPOINT intervention to improve cervical cancer outcomes among women with chronic conditions and social vulnerability. The key products and services to be delivered under this five-year award include: 1) analyzing real-world health data to identify high-risk populations for cervical cancer, 2) using intervention...